Advertisement
0
Email
Glossary
Symfi Lo (Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate)
The Basics
|
News
|
Research
See also:
Medication Side Effects
|
Drug Interactions
|
All HIV Medications
The Basics
An Overview of Symfi Lo (Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate)
(April 11, 2018)
From
AIDSinfo
U.S. Prescribing Information for Symfi Lo (Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate)
(February 2018)
From Mylan Laboratories, Ltd.
News
U.S. Approve a Lower-Dose Efavirenz-Based Generic Fixed-Dose Combination (Symfi Lo)
(February 15, 2018)
From
HIV i-Base
On TheBodyPRO.com
Research
Efavirenz Dosed at 400 mg Provides Adequate Cerebrospinal Fluid Exposure
(January/February 2015)
In
HIV Treatment Bulletin
, from
HIV i-Base
On TheBodyPRO.com
Lower Dose Efavirenz Effective in Two Studies
(December 1, 2014)
In
HIV Treatment Bulletin
, from
HIV i-Base
On TheBodyPRO.com
Efavirenz at 400 mg Compared to Standard 600 mg Dose Has Similar efficacy With Fewer Side effects
(July/August 2013)
To read PDF,
click here
.
In
HIV Treatment Bulletin
, from
HIV i-Base
On TheBodyPRO.com
0
Email
Glossary
My Health Tracker -- ENDING APRIL 2019
Medication and Health Reminders
Assess Your Risk for HIV
Follow Us:
Facebook
,
Twitter
,
RSS
R. Kelly, Sexual Predators, and HIV in a Society Where Black Girls Don't Matter
TheBody's 10 Most Popular HIV-Related Stories of 2018
HIV Drug Prices Keep Rising. Why Is No One Talking About It?
Newly Diagnosed With HIV, I've Got Challenges and a Lot of Blessings in Store for the New Year
Gay Men: It's Time to Stop Calling the Police on One Another for HIV Non-Disclosure
Struggling With Crystal Meth? There Are Research Studies Out There for You
More >>
Advertisement